C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 0.96 AUD -1.03% Market Closed
Market Cap: 106.7m AUD

Wall Street
Price Targets

CYC Price Targets Summary
Cyclopharm Ltd

Wall Street analysts forecast CYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYC is 2.24 AUD with a low forecast of 2.22 AUD and a high forecast of 2.31 AUD.

Lowest
Price Target
2.22 AUD
131% Upside
Average
Price Target
2.24 AUD
134% Upside
Highest
Price Target
2.31 AUD
141% Upside
Cyclopharm Ltd Competitors:
Price Targets
688677
Qingdao NovelBeam Technology Co Ltd
24% Upside
DXCM
Dexcom Inc
27% Upside
7817
Paramount Bed Holdings Co Ltd
4% Upside
PRN
Profound Medical Corp
34% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
5% Upside
SOON
Sonova Holding AG
17% Upside
STIL
Stille AB
37% Upside
PODD
Insulet Corp
14% Upside

Revenue
Forecast

Revenue Estimate
Cyclopharm Ltd

For the last 8 years the compound annual growth rate for Cyclopharm Ltd's revenue is 8%. The projected CAGR for the next 3 years is 50%.

8%
Past Growth
50%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cyclopharm Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Cyclopharm Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-44%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYC's stock price target?
Price Target
2.24 AUD

According to Wall Street analysts, the average 1-year price target for CYC is 2.24 AUD with a low forecast of 2.22 AUD and a high forecast of 2.31 AUD.

What is Cyclopharm Ltd's Revenue forecast?
Projected CAGR
50%

For the last 8 years the compound annual growth rate for Cyclopharm Ltd's revenue is 8%. The projected CAGR for the next 3 years is 50%.

Back to Top